Remedent, Inc. (REMI)
OTCMKTS · Delayed Price · Currency is USD
0.0008
+0.0001 (14.29%)
At close: Sep 9, 2026
Remedent Market Cap
Remedent has a market cap or net worth of $15.42 thousand as of October 9, 2026. It is the 51,639th most valuable company in the world and the 7,680th biggest in the United States. Its market cap has decreased by 91.09% in one year.
Market Cap
15.42K
Enterprise Value
n/a
Revenue
50.10K
Global Rank
Country Rank
#7,680 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 22, 1998, Remedent's market cap has decreased from 207.16K to 15.42K, a decrease of -92.56%. That is a compound annual growth rate of -8.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 15.42K | 33.33% |
| Dec 19, 2025 | 11.56K | -98.91% |
| Dec 18, 2024 | 1.06M | -43.30% |
| Dec 14, 2023 | 1.87M | -43.51% |
| Dec 23, 2022 | 3.31M | 14.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hear AtLast Holdings | 166.40K |
| InnerScope Hearing Technologies | 152.75K |
| LifePoint | 30.63K |
| Medite Cancer Diagnostics | 8.58K |
| Medical International Technology | 8.43K |
| BioLife Sciences | 4.83K |
| OJsys | 3.50K |
| Paradigm Medical Industries | 3.25K |